miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency. by Hassan, Tidi et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Medicine Articles Department of Medicine
1-2-2014
miR-199a-5p silencing regulates the unfolded
protein response in chronic obstructive pulmonary
disease and α1-antitrypsin deficiency.
Tidi Hassan
Royal College of Surgeons in Ireland
Tomás P. Carroll




Royal College of Surgeons in Ireland
Shane J. O'Neill
Royal College of Surgeons in Ireland
See next page for additional authors
This Article is brought to you for free and open access by the Department
of Medicine at e-publications@RCSI. It has been accepted for inclusion in
Medicine Articles by an authorized administrator of e-publications@RCSI.
For more information, please contact epubs@rcsi.ie.
Citation
Hassan T, Carroll TP, Buckley PG, Cummins R, O'Neill SJ, McElvaney NG, Greene CM. miR-199a-5p silencing regulates the
unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency. American Journal of Respiratory
and Critical Care Medicine. 2014;189(3):263-73.
Authors
Tidi Hassan, Tomás P. Carroll, Patrick G. Buckley, Robert Cummins, Shane J. O'Neill, Noel G. McElvaney,
and Catherine M. Greene
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/medart/66
— Use Licence —
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/medart/66
0 
 
miR-199a-5p silencing regulates the unfolded protein response in COPD and α1 
antitrypsin deficiency  
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At-a-glance commentary: The role of miRNAs in regulating the unfolded protein 
response in monocytes in alpha-1 antitrypsin deficiency (AATD) and COPD is unknown. 
miRNAs are differentially expressed in healthy ZZ AATD monocytes, with miR-199a-5p 
expressed 50-fold higher compared to healthy non-AATD controls. miR-199a-5p 
expression is decreased in monocytes from individuals with COPD due to epigenetic 
silencing. Modulation of miR-199a-5p can regulate expression and function of the UPR 
by direct and indirect methods. miR-199a-5p is a key regulator of the UPR in AATD 
monocytes and epigenetic silencing of its expression regulates this process in AAT 
sufficient and AATD-related COPD.  
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RATIONALE: Retention of abnormal alpha-1 antitrypsin activates the unfolded protein 
response in alpha-1 antitrypsin deficient monocytes. The regulatory role of microRNAs in 
unfolded protein responses and chronic obstructive pulmonary disease pathogenesis has 
not been investigated. 
OBJECTIVE: To investigate microRNA expression and function in MM and ZZ 
monocytes and identify microRNA(s) regulating the unfolded protein response.  
METHODS: Peripheral blood monocytes were isolated from asymptomatic and 
symptomatic MM and ZZ individuals for microRNA expression profiling and 
pyrosequencing analysis. microRNA/gene and protein expression was measured with 
quantitative PCR and Western blotting. Overexpression and inhibition studies were 
performed with pre-miR or anti-miR respectively. Luciferase reporter genes were used to 
elucidate direct microRNA-target interactions. Inflammatory cytokines were detected 
using the Meso Scale Discovery Plex assays. 
MEASUREMENTS AND MAIN RESULTS: Forty three microRNAs were 
differentially expressed, with miR-199a-5p most highly upregulated in asymptomatic ZZ 
versus MM monocytes. miR-199a-2 promoter hypermethylation inhibits miR-199a-5p 
expression and was increased in symptomatic MM and ZZ monocytes compared to 
asymptomatic counterparts. GRP78, ATF6, p50 and p65 were increased in symptomatic 
versus asymptomatic ZZ monocytes. Reciprocal down- or upregulation of these markers 
was observed after microRNA modulation. Direct miR-199a-5p targeting of ATF6, p50 
and p65 by miR-199a-5p was demonstrated using luciferase reporter systems. 
Overexpression of miR-199a-5p also decreased other arms of the UPR and expression of 
cytokines that are not putative targets. 
CONCLUSION: miR-199a-5p is a key regulator of the unfolded protein response in 
alpha-1 antitrypsin deficient monocytes and epigenetic silencing of its expression 
regulates this process in chronic obstructive pulmonary disease.  
Abstract word count: 250 
Key words (3-5): Alpha-1 antitrypsin, chronic obstructive pulmonary disease, unfolded 




 Alpha-1 antitrypsin (AAT) is a serine protease inhibitor implicated in the lung 
and liver manifestations of AAT deficiency (AATD), a disorder characterized by decreased 
levels of AAT in the circulation (1). AAT is primarily produced by hepatocytes however, 
other cells including epithelial cells and monocytes can also produce smaller quantities of 
AAT (2-4). Although, chronic obstructive pulmonary disease (COPD) in AATD is mainly 
characterized by decreased serum levels of AAT, it can also be classified as an 
endoplasmic reticulum (ER) stress-related disease resulting in retention of abnormal AAT 
in the ER (5). This occurs due to the Z mutation (Glu342Lys) which causes the protein to 
fold aberrantly and accumulate in the ER. Eukaryotic cells undergo ER stress if there is 
imbalance between the load of correctly folded versus unfolded and/or misfolded proteins 
(6).  
 During ER stress, the ER transduces intracellular signals to the nucleus and 
cytosol (7). One component of ER stress, the unfolded protein response (UPR), is a 
coordinated tripartite management system involving three integral ER-resident 
transmembrane sensors; the protein kinase RNA-like ER kinase (PERK), activating 
transcription factor 6 (ATF6) and inositol requiring kinase 1 (IRE-1). These receptors are 
activated by dissociation of the ER chaperone GRP78, a heat shock protein also known as 
BiP. The next immediate step in UPR engagement is translational attenuation which 
reduces the load of host proteins in the ER and prevents accumulation of unfolded 
proteins. This is caused by PERK via phosphorylation of eukaryotic initiation factor 2  
(eIF2-) and promotes the translation of ATF4, a basic leucine zipper transcription factor 
(8, 9). IRE1 and ATF6 regulate chaperone induction, ER-associated degradation (ERAD) 
and expansion of the ER. IRE-1 oligomerizes and activates its RNAse domain which 
targets X-box binding protein-1 (XBP-1) (10). ATF6 generates a basic leucine zipper 
transcription factor ATF6p50 that migrates to the nucleus and activates transcription of 
genes under the control of ER stress-response elements including XBP-1. The 
ER-stress-induced spliced form of XBP-1 (sXBP-1) translocates into the nucleus and 
binds to ER and UPR stress response elements, activating transcription of ER chaperone 
genes and folding enzymes. NF-B is a family of dimer forming subunits that become 
transcription factors including the canonical p65/p50 heterodimer. IRE1α can complex 
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with IκB kinase via the adaptor protein TNF-receptor activating factor 2, leading to 
degradation of IκBα, an inhibitor of NF-κB. This provides a direct link between ER stress 
and NF-κB activation (11). Indeed, it has been shown that ER accumulation of ZAAT 
leads to activation of the transcription factors NF-κB (12-14).  
 Monocytes from individuals with AATD have been shown to demonstrate an 
exaggerated inflammatory response generated by the accumulation of aberrantly folded 
ZAAT (4). This can have important consequences when these cells migrate into the lung or 
liver and develop into tissue macrophages. In non–AATD related COPD acute and chronic 
exposure to cigarette smoke adversely affects protein metabolism in the lung despite the 
production of the native MAAT protein. Cigarette smoke causes misfolding of nascent 
proteins in the lumen of ER leading to the activation of the UPR (15-17). However, to 
date there have been no studies examining the UPR in monocytes in non-AATD related 
COPD.   
 MicroRNAs (miRNAs) are non-coding RNA molecules that post-transcriptionally 
and mostly negatively regulate a variety of cellular processes by binding to 
complementary seed-sequences at the 3’untranslated region (UTR) of target mRNA (18). 
Recently, the role of miRNAs in the pathogenesis of respiratory diseases has been 
examined including COPD, lung cancer, idiopathic pulmonary fibrosis and cystic fibrosis 
(19). Studies have also shown that ER stress modifies the expression of many miRNAs, 
and a miRNA network that constitutes an additional layer in the regulation of the UPR 
exists in a variety of physiological and pathophysiological contexts (20-22).  
 Epigenetic regulation of miRNA expression can be associated with cigarette 
smoking leading to DNA modification events such as promoter hypermethylation and 
global hypomethylation (23-25). However, the role of miRNAs in the pathogenesis of 
AATD- and non-AATD-related COPD associated with ER stress and the UPR has not yet 
been investigated.  Here, we demonstrate that miRNAs are differentially expressed in 
healthy, asymptomatic AATD ZZ monocytes compared to non-AATD MM monocytes. 
We show that miR-199a-5p is differentially expressed in MM and ZZ monocytes from 
individuals with and without COPD and that this may be related to promoter-specific 
hypermethylation. We also validate several markers of the UPR including ATF6, p50 and 
p65 as direct targets of miR-199a-5p and demonstrate that miR-199a-5p overexpression 
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Asymptomatic MM (n=8, 5 males, 3 females) and ZZ (n=11, 5 males, 6 females) 
individuals, and MM (n=7, 5 males, 2 females) and ZZ (n=11, 6 males, 5 females) 
individuals with COPD were recruited in this study (Table 1). In this study “symptomatic” 
ZZ AATD patients were categorized on the basis of lung disease rather than liver disease 
(an exclusion criterion for the study), which is more classically thought of as resulting from 
protein misfolding and aggregation. Asymptomatic MM individuals were control 
volunteers with no evidence of disease or respiratory symptoms. The meanSEM forced 
expiratory volume in one second (FEV1) for symptomatic MM and ZZ individuals were 
54.19.2% and 44.11.5% predicted respectively. Exclusion criteria included current 
smokers, liver disease, vasculitis, bronchiectasis on high-resolution CT scan and/or other 
extrapulmonary diseases. All MM individuals had a confirmed MM phenotype as 
diagnosed by isoelectric focusing, with serum AAT concentrations within the normal 
range (25-50 µM). ZZ individuals not receiving augmentation therapy were recruited 
from the Irish AATD Registry with previously confirmed AAT levels and Z allele-specific 
PCR. Full informed written consent was obtained and approved by the research ethics 
committee of Beaumont Hospital, Dublin.  
 
Isolation, culture and treatment of peripheral blood monocytes 
Mononuclear cells were isolated from heparinized venous peripheral blood as 
outlined in the online data supplement. MM monocytes were treated with DMSO (vehicle 
control) or Thapsigargin (TG) (Sigma-Aldrich) at 10, 50 or 100nM for 1 hour.  
 
Quantitative assessment of mRNA and miRNA levels 
RNA was isolated and quantified as outlined in the online data supplement. Relative 





miRNA expression profiling using the nCounter miRNA Expression Assay 
miRNAs were profiled from asymptomatic MM and ZZ monocytes (n=3 in each 
group) with the nCounter miRNA Expression Assay (Nanostring Technologies) as 
outlined in the online data supplement.  
 
DNA isolation, sodium bisulfite conversion and pyrosequencing analysis  
Genomic DNA was isolated from the monocytes of asymptomatic and symptomatic 
MM and ZZ individuals and bisulfite converted using the EZ DNA Methylation Direct kit 
(ZymoResearch). Non-methylated, methylated and bisulfite converted DNA were used as 
quality controls. Conditions for PCR amplification and quantitative pyrosequencing 
analysis for the miR-199a-5p promoter and LINE-1 retrotransposable elements are 
provided in the online data supplement. 
 
Luciferase reporter plasmid transfection 
 Briefly, HEK293 cells were transfected with a luciferase reporter vector containing either the 
full-length wild type (WT) 3’UTR of ATF6, NF-B1 for p50 or RELA for p65, or the same plasmids in 
which the miR-199a-5p recognition elements were mutated, and a reference Renilla luciferase reporter 
plasmid pRLSV40 (Promega). The SERPINA1 3’UTR plasmid vector (Origene) was used as a negative 
control. Full details are provided in the online data supplement.  
 
Transfection of pre-miRs and anti-miRs for miRNA overexpression/inhibition, 
western blot analyses and analysis of XBP-1 mRNA splicing and cytokine expression 
These methods are described in the online data supplement. XBP-1 mRNA splicing 
was analyzed using an assay described by Calfon et al. (27). For inflammatory cytokine 
studies, symptomatic ZZ monocytes were treated with Pseudomonas aeruginosa LPS (2 
µg/ml) (Sigma-Aldrich) for 4 hours after miRNA modulation. 
 
IL-8, IL-10, GM-CSF and MCP-1α detection using the Meso Scale Discovery (MSD) 
Custom V-Plex assays. 
 Custom V-Plex assays were used to measure four inflammatory cytokines (IL-8, IL-10, 
GM-CSF and MCP-1α) using a multi-array electrochemiluminescence platform (MSD, 
Gaithersburg, MD). Equal volumes of supernatants were diluted 1 in 4 for IL-10, GM-CSF 
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and MCP-1α and 1 in 50 for IL-8 in the relevant assay diluent in a polypropylene plate. 
Samples (50 µl) were added into wells of the MSD plates and incubated for 2 hours with 
shaking at room temperature. After 3 washes with PBS-Tween, 25 µl of the 1X Detection 
Antibody Blend Solution was added into each well. After 2 hours of incubation at room 
temperature, 150 µl of 2X Read Buffer T was added into each well. The plate was 
immediately read using the Sector Imager 6000 instrument (MSD). Standard curves were 
performed and limits of detection for each assay were measured.  
 
Statistical analysis 
All analyses were performed using GraphPad PRISM 4.0 (San Diego, CA). Results are 
expressed as the mean  SEM and were compared by Student t test or ANOVA as 




miRNA expression is altered and miR-199a-5p is increased in asymptomatic ZZ 
compared to MM monocytes 
RNA isolated from asymptomatic MM and ZZ monocytes was profiled to examine 
the expression of 731 different human miRNAs. Appreciable target detection (normalized 
data after probe and background correction >1) occurred for 246 miRNAs across all 
samples. miRNAs expressed with an average difference of greater and less than 1.5 fold 
were identified for 37 and 6 miRNAs respectively in ZZ monocytes (Figure 1A). Using 
bioinformatics analysis with DIANA miRPath (http://diana.cslab.ece.ntua.gr/pathways), 
these 43 differentially expressed miRNAs were overrepresented in the ER protein folding 
response pathway amongst others (Figure E1 in the online data supplement). 




ER stress up regulates miR-199a-5p expression in MM monocytes 
In order to link this observation to ER stress healthy MM monocytes were treated 
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with TG to induce ER stress. It is well established that treatment with TG induces the 
UPR by depleting Ca2+ stores from the ER and inhibiting the activity of resident Ca2+ 
dependent chaperones. Increasing doses of TG lead to a dose-dependent increase in 
miR-199a-5p expression (p<0.001) (Figure 1B).  
 
miR-199a-5p is down regulated and the miR-199a-2 promoter is hypermethylated in 
symptomatic MM and ZZ monocytes 
We examined the expression of miR-199a-5p in symptomatic MM and ZZ 
monocytes compared to their asymptomatic counterparts by qRT-PCR. Consistent with 
the miRNA profile, the asymptomatic ZZ monocytes demonstrated a higher expression of 
miR-199a-5p by almost 50-fold. However miR-199a-5p expression was decreased in both 
symptomatic MM and ZZ monocytes compared to their asymptomatic counterparts 
(p<0.01, p<0.001 respectively) (Figure 2A).  
We then determined if differential expression of miR-199a-5p was related to 
hypermethylation of its promoter region. Two genes can potentially encode pri-miR-199a, 
the primary precursor of hsa-miR-199a; miR-199a-1 on chromosome 19 (NCBI GeneID 
406976) and miR-199a-2 human on chromosome 1 (NCBI GeneID 406977). miR-199a-2 
has been implicated in diseases involving the UPR (28-30). Its promoter is embedded 
within an intron of Dynamin (DNM3) and is the authentic origin that produces the primary 
transcript harboring miR-199a-3p, miR-199a-5p and miR-214, a miRNA in the same 
intronic cluster (31). Genomic analysis revealed multiple CpG sites in the upstream region 
of miR-199a-5p (+833). Three CpG sites situated upstream of the transcription start site 
(+193) were analyzed for aberrant methylation using bisulfite conversion and sequencing 
(Figure 2D) (n=3 in each MM group, n=6 and 7 in asymptomatic and symptomatic ZZ 
group respectively) (FEV1 54.19.2 and 4411.5% predicted in symptomatic MM and ZZ 
groups, respectively). The CpG sites of interest were observed to be inherently 
hypermethylated by 49.112.7% (mean  SEM) in asymptomatic MM monocytes however, 
this was decreased in the ZZ counterparts (39.8  7.2%, p<0.05). There was an increase in 
the average DNA methylation in both the symptomatic MM (65.18.3%) and ZZ 
monocytes (71.511.2%) compared to their asymptomatic counterparts (p<0.01 for both) 
(Figure 2B). Inhibition of methylation using 5-aza-2’deoxycytidine increased relative 
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miR-199a-5p expression in THP-1 cells (Figure E2). 
 
miR-199a-2 promoter methylation does not correlate with genome-wide methylation 
using LINE-1 repetitive elements 
To determine the degree of global DNA methylation using repetitive elements widely 
distributed in the genome, we analyzed the methylation status of three CpG sites in LINE-1. 
An inverse observation was seen for the asymptomatic and symptomatic MM monocytes 
(43.23.7 vs. 27.93.0, p<0.01) compared to the miR-199a-2 promoter methylation pattern. 
However, similar to the miR-199a-2 promoter methylation, the asymptomatic ZZ 
monocytes demonstrated reduced average methylation (24.92.3%) compared to their MM 
counterparts (p<0.05). There was no difference between the average LINE-1 methylation 
in symptomatic (24.91.3%) versus asymptomatic ZZ monocytes (Figure 2C). 
 
UPR activation is increased in symptomatic versus asymptomatic ZZ monocytes 
The UPR has been shown to be induced in vitro in a variety of cell types in response to 
cigarette smoke exposure (15-17), in experimental animals (32) and in the lungs of 
smokers (33). We sought to determine if this phenomenon occurs in monocytes of ZZ 
individuals with COPD. The expression of GRP78, ATF6, p50 and p65 was measured by 
qRT-PCR and western blot analysis. The relative mRNA and protein expression levels of 
all four markers were significantly increased in symptomatic compared to asymptomatic 
ZZ monocytes (Figure 3 p<0.05 to 0.01). 
 
miR-199a-5p directly targets the 3’UTR of ATF6, NF-B1 and RELA mRNAs 
The UPR markers GRP78, IRE-1, ATF6, p50 and p65 were predicted to be targeted by 
miR-199a-5p (microRNA.org). Figure E3 in the online data supplement shows the 
locations of the predicted miR-199a-5p miRNA recognition elements (MREs) in the 
3’UTR of these transcripts and their corresponding miR-SVR scores. We sought to validate 
the interaction between miR-199a-5p and ATF6, NF-B1(p50) and RELA (p65) mRNAs 
using luciferase reporter plasmids. GRP78 and IRE-1 are validated miR-199a-5p targets 
(34, 35). HEK293 cells were transfected with reporter vectors containing the full-length 
wild-type (WT) 3’UTR or vectors with mutations in specific miR-199a-5p MREs (Figure 4 
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A-C). Co-transfection with pre-miR-199a-5p resulted in significant decreases in luciferase 
expression from the WT vectors compared to scrambled control (p<0.01) (Figure 4 D-F). 
This effect was lost when co-transfections were performed with the MUT-gene specific 
3’UTR plasmid reporters. A SERPINA1-3’UTR reporter plasmid which is not predicted to 
be targeted by miR-199a-5p was used as a negative control.  
 
Modulation of miR-199a-5p levels affects GRP78, ATF6, p50 and p65 expression 
Next the effect of miR-199a-5p overexpression or inhibition was evaluated. In order to 
examine transfection efficiencies of pre-miRs in difficult-to-transfect primary monocytes, 
we first determined the optimal transfection efficiency using a fluorescently labeled 
non-targeting miRIDIAN miRNA mimic at multiple concentrations including 30, 60, 90 
and 120 nM using healthy MM monocytes. Using a dose of 60 nM of miRNA mimic and a 
transfection time period of 24h, 70% transfection efficiency was consistently achieved 
(Figure 5A). Transfection with 60 nM pre-miR-199a-5p led to ~700-fold increase in 
pre-miR 199a-5p expression (Figure 5A) with >80% cell viability assessed using the 
trypan blue dye exclusion test. Conversely, 24-hour transfection with anti-miR-199a-5p led 
to a 15-fold decrease in miR-199a-5p expression (Figure 5B). 
Asymptomatic ZZ monocytes were transfected with 60 nM synthetic pre-miR-199a-5p. 
A scrambled RNA was included as a control. Overexpression of pre-miR-199a-5p 
significantly decreased GRP78, ATF6, p50 and p65 mRNA levels (Figure 5C, p<0.05 to 
p<0.01). Protein expression was also decreased for GRP78 (p<0.05), ATF6 (p<0.01) and 
p65 (p<0.05) however, the difference in p50 protein expression was not significant (Figure 
5D). Conversely, knockdown of miR-199a-5p with 60 nM of anti-miR led to significant 
reciprocal increases in GRP78, ATF60, p50 and p65 mRNA and protein expression (Figure 
5E and F, p<0.05 to p<0.001).  
 
Pre-miR-199a-5p overexpression decreased other arms of the unfolded protein 
response that do not have predictive binding sites for miR-199a-5p 
To examine if pre-miR-199a-5p overexpression has functional effects on the UPR, we 
measured the expression of UPR-inducible genes that are not predicted to be regulated by 
miR-199a-5p. ATF4, CHOP and GADD34 are inducible genes that are activated by PERK. 
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In asymptomatic ZZ monocytes transfected with synthetic pre-miR-199a-5p compared to 
cells transfected with a scrambled control, the relative mRNA expression of ATF4 mRNA 
was slightly reduced whilst CHOP and GADD34 mRNAs were significantly decreased 
(Figure 6A, p<0.05 and p<0.001). GRP58 and GRP94 are regulated by ATF6; expression 
of both of these transcripts was decreased by pre-miR-199a-5p, and significantly so for 
GRP58 (Figure 6B, p<0.01). We explored the activation of the IRE-1 arm of the UPR by 
investigating the expression and splicing of XBP-1. Spliced (s)XBP-1 mRNA levels were 
decreased in ZZ monocytes in pre-miR transfected cells compared with scrambled controls 
(Figure 6C, D).  
 
Modulation of pro-inflammatory cytokines in symptomatic ZZ monocytes treated 
with anti- and pre-miR-199a-5p 
 Finally, to examine if inhibition or overexpression of miR-199a-5p has functional 
effects on inflammatory cytokine expression that has been previously related to the UPR in 
monocytes (4), we measured the secretion of IL-8, IL-10, GM-CSF and MCP-1α in 
supernatants. A dose-dependent treatment showed that 15nM of pre-miR resulted in a 
100-fold overexpression of miR-199a-5p which was closely related to the 50-fold 
induction observed in vivo (Figure 7A). In symptomatic ZZ monocytes, LPS treatment 
led to an induction of all cytokines of interest compared with scrambled controls (Figure 
7B-E). Transfection with 60 nM anti-miR resulted in increased levels of IL-8, IL-10 and 
MCP-1α which were significant (p<0.05) albeit for IL-10. Conversely, 15 and 30 nM of 
pre-miR-199a-5p led to significant decreases in detection of four cytokines (p<0.05 to 




 We have previously reported that the UPR is activated in monocytes from AATD 
individuals and that this affects monocyte function and inflammatory gene expression in 
response to bacterial challenge (4). In this study, we demonstrate that miRNAs are 
differentially expressed in asymptomatic ZZ compared to asymptomatic MM monocytes. 
miR-199a-5p which was overexpressed in ZZ monocytes showed a similar expression 
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profile in MM monocytes treated with thapsigargin, implicating a link between 
miR-199a-5p expression and ER stress in this context. Using bioinformatic tools, we 
observed that putative targets of miR-199a-5p are enriched in the ER protein folding 
pathway. We validated that miR-199a-5p directly targets ATF6, p50 (NF-B1) and p65 
(RELA) 3’UTRs and using gain- and loss-of-function approaches demonstrated that 
miR-199a-5p directly modulates expression of components of the UPR. We also showed 
that miR-199a-5p overexpression can dampen the UPR in ZZ monocytes by decreasing 
levels of downstream targets that are not directly regulated by miR-199a-5p. We also 
provide the first evidence that expression of key components of the UPR are higher in 
monocytes from symptomatic versus asymptomatic ZZ individuals, and that miR-199a-5p 
expression is lower in MM and ZZ monocytes isolated from individuals with COPD 
compared to asymptomatic MM or ZZ individuals. Based on these studies we propose a 
mechanism linking aberrant methylation of upstream CpG sites to differential 
miR-199a-5p expression and UPR activation in individuals with AATD and 
non-AATD-related COPD.  
A number of studies have reported the possible role of miR-199a-5p in ER stress. 
miR-199a-5p has been implicated in the regulation of cell-proliferation, autophagy and 
angiogenesis (31, 36, 37-35). Dai et al. identified that miR-199a-5p is necessary for the 
modulation of hepatic ER stress progression by negatively regulating the IRE-1-related 
pathway (35). In another study, miR-199a-5p was shown to suppress GRP78 and induce 
apoptosis in prostate cancer cells (34). Contrary to our study, Duan et al. demonstrated that 
activation of the UPR suppressed the expression of the miR-199a-5p/miR-214 cluster in 
hepatocellular cancer cell lines (30). Together these suggest that miR-199a-5p 
differentially mediates ER stress in a tissue and/or disease-specific manner. Indeed, we 
have previously reported that different miRNAs functionally target AAT mRNA in a 
cell-specific manner (38). As overexpression of miR-199a-5p also regulates expression of 
components of the three arms of the UPR that are not predicted to be direct targets of 
miR-199a-5p, we conclude that miR-199a-5p is a potent and key regulator of ER stress in 
ZZ monocytes. Previously we demonstrated that UPR activation in asymptomatic ZZ 
monocytes can amplify the host cell immune response (4). Based on the idea that UPR can 
mediate the induction of cytokine expression, all cytokines tested displayed the expected 
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expression pattern following miR-199a-5p modulation. The lack of an increase in 
GM-CSF expression in LPS-treated symptomatic ZZ monocytes transfected with 
antimiR-199a-5p may be due to an already maximal induction of GM-CSF following LPS 
treatment. Collectively the data show that modulation of miR-199a-5p levels reciprocally 
affects expression of inflammatory cytokines, an observation that has functional 
consequences which relate to the pathogenesis of ZZ AATD lung disease. 
Emerging studies into the epigenetic regulation of miRNA have reported that miRNA 
expression can be regulated by DNA methylation and/or histone deacetylation (39). 
Hypermethylated promoters have been observed in clinically cancer-free and 
cancer-bearing smokers in sputum, BAL, alveolar macrophages and lymphoblasts (24, 40, 
41). Current smokers in general have a higher methylation index than ex-smokers (42). A 
recent study reported that miR-199a-5p promoter hypermethylation correlated with its 
down regulation in malignant testicular tumors and that restoration of miR-199a-5p 
expression suppressed tumour invasiveness (29). 
Conversely, LINE-1 repetitive transposable elements, which are widely distributed in 
the human genome with ~500,000 copies, showed hypomethylation in symptomatic MM 
and ZZ monocytes, compared to asymptomatic MM monocytes. LINE-1 elements were 
also hypomethylated in asymptomatic ZZ monocytes. Hypomethylation of LINE-1, 
which reflects global hypomethylation, has been correlated significantly with tumor 
phenotype, progression and prognosis in various cancers (43, 44). One study found 
minimal reduction of LINE-1 methylation in respiratory epithelium under high dosage 
cigarette smoke condensate treatment (45), another reported increased LINE-1 
methylation with higher pack-years of smoking (46) whilst others have reported no 
change in LINE-1 methylation in response to cigarette smoke (47, 48). Recently it has 
been suggested that LINE-1 methylation is not sufficiently sensitive or accurate to 
determine global methylation changes as opposed to locus-specific methylation (49). This 
may apply to the current study in which miR-199a-5p methylation was a locus-specific 
hypermethylation event as opposed to a wider genomic phenomenon.  
 In non-AATD related COPD, studies have indicated that acute and chronic 
exposure to cigarette smoke adversely affects protein metabolism in the lung. It has been 
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shown that in cultured cells, activation of the UPR by cigarette smoke is rapid and dose 
dependent (17, 33). In chronic cigarette smokers, activated UPR is reflected by the 
upregulation at the protein level of UPR chaperones including GRP78 in small airway 
epithelial cells and type II pneumocytes. The mechanism by which cigarette smoke 
induces UPR is not entirely established although direct oxidation of target proteins by 
reactive oxygen/nitrogen species has been proposed to cause ER stress and protein 
misfolding. Cigarette smoke also increases cytosolic calcium suggesting that ER calcium 
depletion may contribute (50). We have shown that miR-199a-5p is downregulated in 
monocytes of MM individuals with COPD which may relate to hypermethylation of the 
miR-199a-2 promoter. This suggests an epigenetic-mediated regulation of miR-199a-5p, 
leading to modulation of the UPR which occurs in both AAT sufficient and AATD COPD. 
To date, no study has explored the potential role of miRNAs in regulating the ER stress in 
these diseases.  
 miR-199a-5p has been linked to non-ER stress studies of COPD and other 
lung diseases. Mizuno et al. reported an increase in miR-199a-5p expression in lung 
tissues from 55 COPD patients and suggested a pathogenic contribution of this miRNA in 
COPD (51). In another study, miR-199a-5p was implicated as part of an early-response 
miRNA signature associated with pulmonary tumorigenesis (52). In idiopathic pulmonary 
fibrosis, miR-199a-5p is significantly increased, induced upon TGF exposure and 
regulates CAV1, a critical mediator of pulmonary fibrosis (53). Here, we propose that the 
altered expression of miR-199a-5p in ZZ monocytes is specific to ER stress due to ZAAT 
accumulation observed in healthy, asymptomatic ZZ monocytes, however the 
pathophysiological role of miR-199a-5p may not be isolated to UPR. 
In conclusion, we show that miR-199a-5p is increased in asymptomatic ZZ monocytes 
likely in response to the activation of ER stress. miR-199a-5p directly targets multiple 
components of the UPR including GRP78, IRE1, ATF6, p50 and p65 and overexpression 
and inhibition of this miRNA modulates the levels of both direct and indirect targets of the 
UPR and proinflammatory cytokine expression. Compared to asymptomatic counterparts, 
miR-199a-5p was decreased in symptomatic MM and ZZ monocytes, an event which is 
likely to be mediated by promoter-specific hypermethylation (Figure 8). This knowledge 
adds another layer of complexity in miRNA regulation of the UPR, which may have 
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potential for the development of future therapies for both AATD-related COPD, and other 
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FIGURE LEGENDS  
Figure 1. Altered miRNA expression in asymptomatic ZZ versus MM monocytes. A,  
miRNAs expressed with an average difference of greater and less than 1.5 fold (37, 6 
miRNAs respectively) in asymptomatic ZZ monocytes (n=3) compared to asymptomatic 
MM monocytes (n=3) were profiled using the nCounter miRNA Expression Assay. B, 
Relative expression of miR-199a-5p normalized to U6 snRNA in MM monocytes (1 x 105 
cells, n=3, separate cultures in triplicate) treated with increasing dose of thapsigargin (10, 
50, 100nM) for 1 hour using TaqMan miRNA assays. Data are represented as mean  
SEM and were compared by ANOVA (***p<0.001).  
 
Figure 2. MiR-199a-5p expression, miR-199a-2 promoter methylation and global 
methylation in asymptomatic and symptomatic MM and ZZ monocytes A, Relative 
expression of miR-199a-5p normalized to U6 snRNA in asymptomatic and symptomatic 
MM (n=7 in each group) and ZZ monocytes (n=10 asymptomatic and n=11 symptomatic) 
using Taqman miRNA assays. Values presented in y-logarithmic 10. B, Average 
methylation percentage of three CpG sites on the miR-199a-2 promoter in asymptomatic 
and symptomatic MM (n=3 in each group) and ZZ monocytes (n=6 and 7 in each group 
respectively) using pyrosequencing assays. C, Average percentage LINE-1 methylation in 
asymptomatic and symptomatic MM and ZZ monocytes (n=3 in each group). Data are 
represented as mean  SEM and were compared by student t-test (non-parametric, 
one-tailed) (*p<0.05, **p<0.01, ***p<0.001).  D, A schematic illustration of the 
miR-199a-2 gene embedded in the antisense strand within an intron of Dynamin in 
human chromosome 1.  Three CpG sites (indicated as black pin needles) closest to the 
transcription start site in the miR-199a-2 promoter were analyzed.   
 
Figure 3. Markers of the unfolded protein response are increased in symptomatic ZZ 
monocytes. Relative expression of GRP78, ATF6, p50 and p65 A, mRNA and B, protein 
in symptomatic ZZ monocytes (n=7) compared with asymptomatic ZZ monocytes (n=6). 
mRNA and protein relative expression were analyzed in triplicates by qRT-PCR and 
Western blot respectively and normalized to GAPDH. Data are represented as mean  
SEM and were compared by student t-test (non-parametric, one-tailed) (*p<0.05, 
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**p<0.01).   
 
Figure 4. MiR-199a-5p target validation in ATF6, p50 and p65.  The miR-199a-5p 
binding site predictions for A, ATF6, B, p50 and C, p65 3’UTR by microRNA.org. 
Vertical lines represent Watson-Crick base pairs whilst colons represent wobble base pairs. 
The underlined letters indicate the mutations inserted by site-directed mutagenesis.  
Relative luciferase activities in transiently transfected HEK293 cells (1x105 cells in 
triplicate) were measured using D, ATF6, E, p50 and F, p65 luciferase reporters and 
constitutive Renilla luciferase reporter pRLSV40 in HEK293 cells analyzed 48 hours 
after co-transfection with no pre-miR (No PM), scrambled (ScR) and pre-miR-199a-5p 
(PM). SERPINA1 3’UTR luciferase reporter was used as a negative control. Firefly 
luciferase activity was normalized to the Renilla luciferase activity. Data are represented 
as mean ± SEM and were compared by student t-test (non-parametric, one-tailed) 
(**p<0.01). 
 
Figure 5.  Direct targets in the unfolded protein response can be modulated with 
pre-miR- and anti-miR-199a-5p. A (top), Asymptomatic MM monocytes were 
nontransfected (NT) and transfected (T) with 60nM pierce dye547-labelled non-targeting 
miRIDIAN miRNA control to monitor transfection efficiency.  Relative expression of 
miR-199a-5p in asymptomatic MM monocytes after 60 nM of pre-miR- (bottom) and B, 
anti-miR-199a-5p normalized to U6 snRNA using Taqman assays. Relative expression of 
GRP78, ATF6, p50 and p65 C, mRNA and D, protein in asymptomatic ZZ monocytes 
(1x105 cells in triplicate, n=3) treated with 60 nM of scrambled RNA (ScR) and pre-miRs 
(PM). Relative expression of GRP78, ATF6, p50 and p65 E, mRNA and F, protein in 
asymptomatic ZZ monocytes (n=3) treated with 60 nM of scrambled RNA (ScR) and 
anti-miRs (AM). Relative expression of miRNA and protein were analyzed in triplicate 
using qRT-PCR and Western blot respectively, normalized to GAPDH. Data are 
represented as mean  SEM and were compared by student t-test (non-parametric, 
one-tailed) (*p<0.05, **p<0.01,***p<0.001).   
 
Figure 6. Non-direct targets in the unfolded protein response can be modulated with 
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pre-miR-199a-5p. Relative expression of mRNAs in the A, PERK arm, B, ATF6 arm and 
C, IRE-1 arm of the unfolded protein response in asymptomatic ZZ monocytes (n=3, 
cultured in triplicate) treated with either 60 nM scrambled RNA (ScR) or 
pre-miR-199a-5p (PM) using qRT-PCR normalized to GAPDH. D, A representative gel 
indicating spliced (sXBP-1) and unspliced (uXBP-1) in asymptomatic ZZ monocytes 
treated with either 60 nM scrambled RNA (ScR) or pre-miR-199a-5p (PM). Data are 
represented as mean  SEM and were compared by student t-test (non-parametric, 
one-tailed) (*p<0.05, **p<0.01, ***p<0.001). 
 
Figure 7. Pro-inflammatory functional effects can be modulated with anti- and 
pre-miR-199a-5p. A, Relative expression of miR-199a-5p normalized to U6 snRNA using 
Taqman assays in symptomatic ZZ monocytes (n=3) after transfection with 15 nM and 
30nM of pre-miR. Levels of B, IL-8 C, IL-10 D, GM-CSF and E, MCP-1α in 
symptomatic ZZ monocytes (n=3) transfected with 60 nM anti-miR or 15 and 30 nM 
pre-miR using the Meso Scale Discovery Pro-Inflammatory Custom V-Plex assays. Data 
are represented as mean  SEM and were compared by either ANOVA or the student 
t-test (non-parametric, one-tailed) (*p<0.05, **p<0.01 , ***p<0.001). 
 
Figure 8. Model for the role and regulation of miR-199a-5p in the unfolded protein 
response (UPR) in asymptomatic and symptomatic ZZ monocytes. The accumulation of 
the aberrant ZAAT protein activates the UPR which in turn induces miR-199a-5p 
expression. In asymptomatic ZZ, elevated miR-199a-5p could negatively regulate ER 
stress by targeting the 3’UTR mRNAs of GRP78, ATF6, NF-B1 (p50) and RELA (p65). 
In symptomatic ZZ monocytes, hypermethylated CpG sites in the miR-199a-5p promoter 


















Asymptomatic MM 8 (5:3) 30.711.2 103.39.5 83.25.0 0 
Symptomatic MM 7 (5:2) 46.78.1 54.19.2 59.919.0 2913.1 
Asymptomatic ZZ 11 (5:6) 34.39.2 978.6 96.76.4 0 
Symptomatic ZZ 11(6:5) 40.78.7 4411.5 51.612.4 18.611.2 
Values are mean ± standard error of the mean. 
 
 
 
 
 
